Sawai Group Holdings Co., Ltd. (SWGHF)

38.18 0.00 (0.00%) At close: 09:30AM EDT

Sawai Group Holdings Co., Ltd.

5-2-30, Miyahara
Yodogawa-ku
Osaka 532-0003
Japan
81 6 6105 5818
https://www.sawaigroup.holdings

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 3,393

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mitsuo Sawai	Chairman, President, Group CEO & Group COO	N/A	N/A	1956
Jun Tsujii	General Manager of the Group Finance Department	N/A	N/A	N/A
Mr. Yasushi Kora	General Manager of Public Relations & Investor Relations Office	N/A	N/A	N/A
Mr. Seiji Nishimura	Corporate Officer & Group Chief Marketing Officer	N/A	N/A	N/A
Mr. Kazuhiko Sueyoshi	Deputy Group Chief Executive Officer	N/A	N/A	1957
Mr. Toru Terashima	Senior Managing Executive Officer, Group Chief Quality & Safety Officer and Director	N/A	N/A	1959
Ms. Nobuko Sugimoto	Group Chief Intellectual Property Officer	N/A	N/A	N/A
Mr. Toshiya Hasuo	Group Chief Production Officer	N/A	N/A	N/A
Mr. Motohiko Kimura	Senior Managing Executive Officer	N/A	N/A	N/A
Mr. Shoji Yokota Ph.D.	Senior Managing Executive Officer, Group Chief Research & Development Officer and Director	N/A	N/A	1957

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.

Corporate governance

Sawai Group Holdings Co., Ltd.’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.